{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:46:20Z","timestamp":1767134780567,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd007280.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T00:00:00Z","timestamp":1337126400000}}],"reference-count":47,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007280.pub3","type":"journal-article","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T16:19:27Z","timestamp":1336666767000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Carnitine for fatigue in multiple sclerosis"],"prefix":"10.1002","volume":"2012","author":[{"given":"Aaron M","family":"Tejani","sequence":"first","affiliation":[{"name":"University of British Columbia; Therapeutics Initiative; 2176 Health Sciences Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wasdell","sequence":"additional","affiliation":[{"name":"Fraser Health Authority; Pharmacy Services; 3935 Kincaid Street Burnaby Canada V5G 2X6"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rae","family":"Spiwak","sequence":"additional","affiliation":[{"name":"Fraser Health c\/o Burnaby Hospital; Research; 3935 Kincaid Street Burnaby BC Canada V5G 2X6"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Rowell","sequence":"additional","affiliation":[{"name":"Woodward Library, University of British Columbia; Libraries; 2198 Health Sciences Mall Vancouver Canada BC V6T 1Z3"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabita","family":"Nathwani","sequence":"additional","affiliation":[{"name":"University of British Columbia; Faculty of Pharmaceutical Sciences; Vancouver Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,5,16]]},"reference":[{"issue":"1-2","key":"10.1002\/14651858.CD007280.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2003.11.005","article-title":"Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial","volume":"218","author":"Tomassini","year":"2004","journal-title":"Journal Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD007280.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1191\/135248506ms1275oa","article-title":"Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue","volume":"12","author":"Lebrun","year":"2006","journal-title":"Multiple Sclerosis"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0003|cit3","unstructured":"Efficacy of L-carnitine Versus Placebo in the Treatment of Fatigue in Multiple Sclerosis (FACTSEP) Ongoing study June 2010"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3310\/hta4270","article-title":"Treatments for fatigue in multiple sclerosis: a rapid and systematic review","volume":"4","author":"Branas","year":"2000","journal-title":"Health Technology Assessment"},{"issue":"10","key":"10.1002\/14651858.CD007280.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.dld.2007.06.013","article-title":"L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study","volume":"39","author":"Ciacci","year":"2007","journal-title":"Digestive Liver Disease"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1196\/annals.1320.016","article-title":"L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysis","volume":"1033","author":"Cruciani","year":"2004","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0007|cit7","unstructured":"Cylert (package insert) Abbott Laboratories: East Chicago, Illinois 1999"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/S0317167100048691","article-title":"The impact of fatigue on patients with multiple sclerosis","volume":"21","author":"Fisk","year":"1994","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2648.2002.02129.x","article-title":"The cooling-suit: case studies of its influence on fatigue among eight individuals with multiple sclerosis","volume":"37","author":"Flensner","year":"2002","journal-title":"Journal of Advanced Nursing"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0010|cit10","first-page":"135","article-title":"Symptomatic fatigue in multiple sclerosis","volume":"65","author":"Freal","year":"1984","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"6","key":"10.1002\/14651858.CD007280.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1440-1819.1996.tb00573.x","article-title":"Serum carnitine and disabling fatigue in multiple sclerosis","volume":"50","author":"Fukazawa","year":"1996","journal-title":"Psychiatry and Clinical Neurosciences"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1191\/1352458502ms777oa","article-title":"A double-blind pilot study of the effect of Prokarin on fatigue in multiple sclerosis","volume":"8","author":"Gillson","year":"2002","journal-title":"Multiple Sclerosis"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/sj.bjc.6600413","article-title":"Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients","volume":"86","author":"Graziano","year":"2002","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0014|cit14","first-page":"1","article-title":"Carnitine for Alzheimer's Disease","volume":"230","author":"Helman","year":"2005","journal-title":"Arbor Clinical Nutrition Updates"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/135245859900500103","article-title":"The fatigue descriptive scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis","volume":"5","author":"Iriarte","year":"1999","journal-title":"Multiple Sclerosis"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0016|cit16","first-page":"16","article-title":"Effects of multiple sclerosis on occupational and career patterns multiple sclerosis on occupational and career patterns","volume":"13","author":"Jackson","year":"1991","journal-title":"Axone"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-510X(02)00312-X","article-title":"Quality of life in patients with multiple sclerosis: the impact of fatigue and depression","volume":"205","author":"Janardhan","year":"2002","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1545968306298934","article-title":"Origin of Fatigue in Multiple Sclerosis: Review of the Literature","volume":"22","author":"Kos","year":"2008","journal-title":"Neurorehabilitation and Neural Repair"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneur.1988.00520280085020","article-title":"Fatigue in multiple sclerosis","volume":"45","author":"Krupp","year":"1988","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1212\/WNL.45.11.1956","article-title":"Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo","volume":"45","author":"Krupp","year":"1995","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD007280.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.mco.0000232905.89662.60","article-title":"Antimyopathic Effects of Carnitine and Nicotine","volume":"9","author":"Laviano","year":"2006","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1191\/135248506ms1275oa","article-title":"Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue","volume":"12","author":"Lebrun","year":"2006","journal-title":"Multiple Sclerosis"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0023|cit23","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/ajcn\/86.6.1738","article-title":"L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial","volume":"86","author":"Malaguarnera","year":"2007","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s002800050963","article-title":"Increased urinary losses of carnitine during ifosfamide chemotherapy","volume":"44","author":"Marthaler","year":"1999","journal-title":"Cancer Chemotherapy Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007280.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1191\/1352458502ms779oa","article-title":"Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis","volume":"8","author":"Mostert","year":"2002","journal-title":"Multiple Sclerosis"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1017\/S0317167100047107","article-title":"Amantadine therapy for fatigue in multiple sclerosis","volume":"12","author":"Murray","year":"1985","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<339::AID-JCP4>3.0.CO;2-B","article-title":"Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system","volume":"182","author":"Peluso","year":"2000","journal-title":"Journal of Cell Physiology"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2165\/00002512-200320100-00004","article-title":"Levocarnitine administration in elderly subjects with rapid muscle fatigue","volume":"20","author":"Pistone","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000119325","article-title":"Amantadine and L-carnitine treatment of chronic fatigue syndrome","volume":"35","author":"Plioplys","year":"1997","journal-title":"Neuropsychobiology"},{"issue":"4","key":"10.1002\/14651858.CD007280.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic Criteria for Multiple Sclerosis: 2005 revisions to the Macdonald Criteria","volume":"59","author":"Polman","year":"2005","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD007280.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for Multiple Sclerosis: guide-lines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD007280.pub3-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002818.pub2","article-title":"Amantadine for fatigue in multiple sclerosis","author":"Pucci","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0035|cit35","unstructured":"Multiple Sclerosis Council for Clinical Practice Guidelines Fatigue and Multiple Sclerosis: Evidence-Based Management Strategies for Fatigue in Multiple Sclerosis Paralyzed Veterans of America 1998"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archneur.61.2.176","article-title":"Fatigue in Multiple Sclerosis: is the picture getting simpler or more complex?","volume":"61","author":"Racke","year":"2004","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/jnnp.72.2.179","article-title":"Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two-centre phase 2 study","volume":"72","author":"Rammohan","year":"2002","journal-title":"Journal of Neurologu, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007280.pub3-BIB0038|cit38","first-page":"182","article-title":"Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients","volume":"25","author":"Rossini","year":"2007","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"9","key":"10.1002\/14651858.CD007280.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.clineuro.2007.10.001","article-title":"Psychological aspects of multiple sclerosis","volume":"110","author":"Sa","year":"November 2008","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/phrs.1998.0438","article-title":"Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine","volume":"39","author":"Sayed-Ahmed","year":"1999","journal-title":"Pharmacological Research"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1749-6632.1965.tb20235.x","article-title":"Problems of experimental trials of therapy in Multiple Sclerosis: Report by the panel of the evaluation of experimental trials in Multiple Sclerosis.","volume":"122","author":"Schumacher","year":"1965","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0042|cit42","first-page":"211","article-title":"Fatigue in multiple sclerosis: Current understanding and future direction","volume":"39","author":"Schwid","year":"2002","journal-title":"Journal of rehabilitation Research and Development"},{"issue":"4","key":"10.1002\/14651858.CD007280.pub3-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001330","article-title":"Aminopyridines for symptomatic treatment in multiple sclerosis","author":"Solari","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00415-006-0247-3","article-title":"Fatigue in Multiple Sclerosis Persists Over Time: a longitudinal study","volume":"253","author":"Tellez","year":"2006","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0045|cit45","unstructured":"United Kingdom Multiple Sclerosis Society Symptom Management Survey United Kingdom Multiple Sclerosis Society 1997"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1212\/WNL.42.8.1468","article-title":"A double-blind, randomized crossover trial of pemoline in fatigue associated with multiple sclerosis","volume":"42","author":"Weinshenker","year":"1992","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD007280.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00415-002-0765-6","article-title":"Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study","volume":"249","author":"Zifko","year":"2002","journal-title":"Journal of Neurology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007280.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T05:57:40Z","timestamp":1725515860000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007280.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,16]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007280.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,16]]}}}